Isatuximab and pomalidomide for the treatment of MM
Accelerating assessment of therapies in hematology
GATA2 and its influence on AML
MRD for acute leukemias: opinion from both sides of the Atlantic
Alan Burnett et al.
ASH 2017: CLL combination therapy highlights